Organogenesis Holdings Inc (ORGO) - Total Liabilities

Latest as of September 2025: $123.85 Million USD

Based on the latest financial reports, Organogenesis Holdings Inc (ORGO) has total liabilities worth $123.85 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Organogenesis Holdings Inc (ORGO) equity growth momentum to track the company's year-over-year net asset growth rate.

Organogenesis Holdings Inc - Total Liabilities Trend (2001–2024)

This chart illustrates how Organogenesis Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See ORGO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Organogenesis Holdings Inc Competitors by Total Liabilities

The table below lists competitors of Organogenesis Holdings Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Chemclin Diagnostics Co. Ltd. A SHG:688468	China	CN¥344.10 Million
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A SHE:301290	China	CN¥238.50 Million
Akebia Ther NASDAQ:AKBA	USA	$343.95 Million
Gigasolar Materials TWO:3691	Taiwan	NT$5.37 Billion
APAC Opto Electronics TWO:4908	Taiwan	NT$179.26 Million
Zbom Cabinets Co Ltd SHG:603801	China	CN¥2.95 Billion
HCK Capital Group Bhd KLSE:7105	Malaysia	RM782.44 Million
Panda Dairy Corp SHE:300898	China	CN¥92.42 Million

Liability Composition Analysis (2001–2024)

This chart breaks down Organogenesis Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ORGO market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.32	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Organogenesis Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Organogenesis Holdings Inc (2001–2024)

The table below shows the annual total liabilities of Organogenesis Holdings Inc from 2001 to 2024.

Year	Total Liabilities	Change
2024-12-31	$112.57 Million	-37.93%
2023-12-31	$181.36 Million	-1.27%
2022-12-31	$183.69 Million	-9.03%
2021-12-31	$201.92 Million	+36.06%
2020-12-31	$148.41 Million	-10.11%
2019-12-31	$165.10 Million	+41.55%
2018-12-31	$116.64 Million	+689.22%
2017-12-31	$14.78 Million	+30.46%
2016-12-31	$11.33 Million	+2620.33%
2015-12-31	$416.43K	-91.14%
2001-12-31	$4.70 Million	--

About Organogenesis Holdings Inc

NASDAQ:ORGO USA Drug Manufacturers - Specialty & Generic

Market Cap

$340.12 Million

Market Cap Rank

#14017 Global

#3373 in USA

Share Price

$2.68

Change (1 day)

+1.90%

52-Week Range

$2.24 - $6.54

All Time High

$150.00